The novel desmopressin analogue [V(4)Q(5)]dDAVP inhibits angiogenesis, tumour growth and metastases in vasopressin type 2 receptor-expressing breast cancer models

Desmopressin (dDAVP) is a safe haemostatic agent with previously reported antitumour activity. It acts as a selective agonist for the V2 vasopressin membrane receptor (V2r) present on tumour cells and microvasculature. The purpose of this study was to evaluate the novel peptide derivative [V(4)Q(5)]...

Descripción completa

Detalles Bibliográficos
Autores principales: GARONA, JUAN, PIFANO, MARINA, ORLANDO, ULISES D., PASTRIAN, MARIA B., IANNUCCI, NANCY B., ORTEGA, HUGO H., PODESTA, ERNESTO J., GOMEZ, DANIEL E., RIPOLL, GISELLE V., ALONSO, DANIEL F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2015
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4441290/
https://www.ncbi.nlm.nih.gov/pubmed/25846632
http://dx.doi.org/10.3892/ijo.2015.2952

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4441290/
https://www.ncbi.nlm.nih.gov/pubmed/25846632
http://dx.doi.org/10.3892/ijo.2015.2952

Ejemplares similares